Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Type II and Type III SMA
NCT00568802Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jan 2004
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in spinal muscular atrophy (SMA), sponsored by Stanford University. Started Jan 2004; status: completed.
02
Drugs
hydroxyurea
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on NCT00568802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568802.